SAPONARO, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 1.823
EU - Europa 742
AS - Asia 309
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 2.881
Nazione #
US - Stati Uniti d'America 1.815
DE - Germania 171
CN - Cina 169
IT - Italia 161
PL - Polonia 144
TR - Turchia 87
UA - Ucraina 79
SE - Svezia 53
GB - Regno Unito 51
RU - Federazione Russa 29
VN - Vietnam 29
FI - Finlandia 25
BE - Belgio 17
CA - Canada 8
HK - Hong Kong 8
IN - India 8
FR - Francia 4
BR - Brasile 3
AT - Austria 2
AU - Australia 2
EU - Europa 2
IL - Israele 2
NL - Olanda 2
CH - Svizzera 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
KH - Cambogia 1
KR - Corea 1
MC - Monaco 1
PK - Pakistan 1
Totale 2.881
Città #
Fairfield 279
Woodbridge 268
Ashburn 145
Warsaw 144
Ann Arbor 135
Houston 134
Wilmington 117
Chandler 112
Jacksonville 102
Seattle 101
Cambridge 91
Ferrara 84
Beijing 48
Izmir 38
Nanjing 30
Dong Ket 28
Shanghai 25
Princeton 24
Milan 21
Brussels 17
San Diego 17
Boardman 16
Shenyang 12
Munich 10
Changsha 9
Hebei 8
Jiaxing 8
New York 8
Redwood City 8
Addison 7
Bremen 7
Mcallen 7
Hong Kong 6
Los Angeles 6
Montréal 6
Nanchang 6
Auburn Hills 5
Des Moines 5
Falls Church 5
Helsinki 5
San Mateo 5
Bari 4
Cagliari 4
Jinan 4
London 4
Mountain View 4
Tianjin 4
Zhengzhou 4
Dearborn 3
Kunming 3
Mysore 3
Philadelphia 3
Washington 3
Calvizzano 2
Chicago 2
Düsseldorf 2
Kitzbuhel 2
Mumbai 2
Padova 2
Tappahannock 2
Toronto 2
West Jordan 2
Xian 2
Ardabil 1
Ariyalūr 1
Atlanta 1
Augusta 1
Cormeilles-en-Parisis 1
Dallas 1
Greenwich 1
Guangzhou 1
Haikou 1
Hangzhou 1
Hanoi 1
Harbin 1
Holmdel 1
Hounslow 1
Indiana 1
Jerusalem 1
Kilburn 1
Lanzhou 1
Leawood 1
Mansfield 1
Monaco 1
Monmouth Junction 1
Ningbo 1
Nole 1
Norwalk 1
Orange 1
Osasco 1
Perm 1
Piraeus 1
Porto 1
San Jose 1
Seongnam 1
Seriate 1
Stockholm 1
Tel Aviv 1
Tokyo 1
Uberlândia 1
Totale 2.209
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 285
Design and Synthesis of New A2A and A3 Adenosine Receptors Antagonists 177
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 149
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 131
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 131
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 129
null 124
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 124
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 121
null 121
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 119
null 118
A3 adenosine receptor antagonists: History and future perspectives 117
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 116
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 110
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists. 108
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 108
null 107
null 103
null 96
null 84
null 83
Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy 32
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 25
Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists 22
Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists. 20
Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists 19
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors 19
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists 17
Synthesis and Biological Evaluation of Novel 2-Amino-3-Aroyl-4-Neopentyl-5-Substituted Thiophene Derivatives as Allosteric Enhancers of the A1 Adenosine Receptor 16
Transient receptor potential ankyrin 1 (TRPA1) antagonists 5
Totale 2.936
Categoria #
all - tutte 9.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 425
Totale 9.499


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019222 0 0 0 0 0 0 0 0 0 0 95 127
2019/2020657 88 27 31 97 54 73 61 60 54 59 37 16
2020/2021489 37 31 26 74 60 41 17 52 9 51 41 50
2021/2022321 20 17 31 15 28 18 15 15 22 33 23 84
2022/2023286 29 37 4 39 37 40 22 16 37 1 12 12
2023/2024158 17 16 8 5 22 42 6 33 2 6 1 0
Totale 2.936